Top

Tag: NantPharma


Regulations

Court Confirms Sorrento Therapeutics, Inc.’s $125 Million Arbitration Award Against NantPharma, LLC

March 17, 2023

Via: PR Newswire

Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, announced that on March 16, 2023, the LA County Superior Court confirmed an arbitration award of $125 million in damages, to […]